Company intelligence / Profile preview

Emerging Therapy Solutions

Minneapolis, Minnesota, USA

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Emerging Therapy Solutions does not develop therapeutics but provides risk management, care navigation, and provider contracting solutions for payers managing members requiring cell/gene therapies, transplants, and other high-cost therapies. Its primary clinical outcomes are in optimizing access, payer spend forecasting, and care navigation for advanced therapies.

Therapeutic areas: OtherRare Diseases
Modalities: Cell therapyGene therapyTransplant (Solid organ, Bone marrow)
Industry: Consulting

Partnerships

COEUSCareMetx/OutcomeRx

Beyond the preview

Go deeper on Emerging Therapy Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerging Therapy Solutions.

Explore the full profile